These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 33021860

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Retrolental Bullous Retinal Detachment as the Presenting Feature of Vogt-Koyanagi-Harada Disease in an Elderly Indian Female: Diagnostic and Therapeutic Challenge.
    Kumar Menia N, Bansal R, Gupta V.
    Ocul Immunol Inflamm; 2024 May; 32(4):429-432. PubMed ID: 36897931
    [Abstract] [Full Text] [Related]

  • 23. Suprachoroidal triamcinolone acetonide injection: a novel therapy for serous retinal detachment due to Vogt-Koyanagi Harada disease.
    Tabl AA, Elsayed MA, Tabl MA.
    Eur J Ophthalmol; 2022 Nov; 32(6):3482-3488. PubMed ID: 35266801
    [Abstract] [Full Text] [Related]

  • 24. Changes in Central Macular Thickness and Retinal Nerve Fiber Layer Thickness in Eyes with Vogt-Koyanagi-Harada Disease: A 2-Year Follow-Up Study.
    Han YS, Shin KS, Lee WH, Kim JY.
    Ophthalmologica; 2018 Nov; 239(2-3):143-150. PubMed ID: 29339644
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The effect of pulse steroid treatment of ten days' long on the improvement of bacillary layer detachment in a patient with Vogt-Koyanagi Harada disease.
    Atas F, Kaya M, Saatci AO.
    Rom J Ophthalmol; 2021 Nov; 65(2):183-186. PubMed ID: 34179585
    [Abstract] [Full Text] [Related]

  • 28. Resolution of subretinal fluid with systemic corticosteroid treatment in acute Vogt-Koyanagi-Harada disease.
    Nazari H, Rao NA.
    Br J Ophthalmol; 2012 Nov; 96(11):1410-4. PubMed ID: 22942161
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Bacillary Layer Detachment in Acute Vogt-Koyanagi-Harada Disease.
    Ataş F, Kaya M, Saatci AO.
    Turk J Ophthalmol; 2022 Dec 28; 52(6):400-404. PubMed ID: 36578215
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [A rare case of ocular scarrings in a patient with Vogt-Koyanagi-Harada disease].
    Belmokhtar A, Daoudi R.
    Pan Afr Med J; 2017 Dec 28; 28():313. PubMed ID: 29721143
    [Abstract] [Full Text] [Related]

  • 34. Retinal Pigment Epithelium Detachment in Acute Vogt-Koyanagi-Harada Disease: An Unusual Finding at Presentation.
    Khochtali S, Ksiaa I, Megzari K, Khairallah M.
    Ocul Immunol Inflamm; 2019 Dec 28; 27(4):591-594. PubMed ID: 29513616
    [Abstract] [Full Text] [Related]

  • 35. Evaluation of pulse corticosteroid therapy for vogt-koyanagi-harada disease assessed by optical coherence tomography.
    Yamanaka E, Ohguro N, Yamamoto S, Nakagawa Y, Imoto Y, Tano Y.
    Am J Ophthalmol; 2002 Sep 28; 134(3):454-6. PubMed ID: 12208266
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Comparison of the optical coherence tomographic characters between acute Vogt-Koyanagi-Harada disease and acute central serous chorioretinopathy.
    Lin D, Chen W, Zhang G, Huang H, Zhou Z, Cen L, Chen H.
    BMC Ophthalmol; 2014 Jun 28; 14():87. PubMed ID: 24974016
    [Abstract] [Full Text] [Related]

  • 39. Long-term Outcomes of Limited Vogt-Koyanagi-Harada Syndrome.
    Chew SK, Levy J, Rogers S, Lim LL.
    Am J Ophthalmol; 2016 Jul 28; 167():52-6. PubMed ID: 27066721
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.